Burkitt's lymphoma differential diagnosis

Revision as of 16:23, 27 November 2012 by Soumya Sachdeva (talk | contribs)
Jump to navigation Jump to search

Burkitt's lymphoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Burkitt's lymphoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study Of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X Ray Findings

CT

MRI

Biopsy

Other Imaging Studies

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Burkitt's lymphoma differential diagnosis On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Burkitt's lymphoma differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Burkitt's lymphoma differential diagnosis

CDC on Burkitt's lymphoma differential diagnosis

Burkitt's lymphoma differential diagnosis in the news

Blogs on Burkitt's lymphoma differential diagnosis

Directions to Hospitals Treating Burkitt's lymphoma

Risk calculators and risk factors for Burkitt's lymphoma differential diagnosis

Assistant Editor-in-Chief: Soumya Sachdeva

It ,sometimes , becomes very difficult for the pathologist to differentiate between burkitt's lymphoma and diffuse large B cell lymphoma.They can be differentiated only by the fact that there is a very high proliferative fraction seen in patients with burkitt's lymphoma(i.e.,essentially 100% of tumor cells are in cycle) caused by c-myc deregulation.


References


Template:WikiDoc Sources